| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Net income | -0.3 | -0.3 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +23.3% |
|---|---|
| Gross margin | 100.0% |
10-Q filed with the SEC, OTC: SKVI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Skinvisible, Inc.: key numbers
- Share price
- $0.1800Close, Nov 13
- Market cap
- $973K
- Shares outstanding
- 5.4MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.